Cite
Indolyl-3-acryloylglycine (IAG) is a putative diagnostic urinary marker for autism spectrum disorders.
MLA
Bull, Gillian, et al. “Indolyl-3-Acryloylglycine (IAG) Is a Putative Diagnostic Urinary Marker for Autism Spectrum Disorders.” Medical Science Monitor : International Medical Journal of Experimental and Clinical Research, vol. 9, no. 10, Oct. 2003, pp. CR422-CR425. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=14523330&authtype=sso&custid=ns315887.
APA
Bull, G., Shattock, P., Whiteley, P., Anderson, R., Groundwater, P. W., Lough, J. W., & Lees, G. (2003). Indolyl-3-acryloylglycine (IAG) is a putative diagnostic urinary marker for autism spectrum disorders. Medical Science Monitor : International Medical Journal of Experimental and Clinical Research, 9(10), CR422-CR425.
Chicago
Bull, Gillian, Paul Shattock, Paul Whiteley, Roz Anderson, Paul W Groundwater, John W Lough, and George Lees. 2003. “Indolyl-3-Acryloylglycine (IAG) Is a Putative Diagnostic Urinary Marker for Autism Spectrum Disorders.” Medical Science Monitor : International Medical Journal of Experimental and Clinical Research 9 (10): CR422-CR425. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=14523330&authtype=sso&custid=ns315887.